Ignite Creation Date:
2025-12-24 @ 7:58 PM
Ignite Modification Date:
2026-04-23 @ 3:10 AM
Study NCT ID:
NCT01662804
Status:
COMPLETED
Last Update Posted:
2021-05-27
First Post:
2012-08-07
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Humanized 3F8 Monoclonal Antibody (Hu3F8) When Combined With Interleukin-2 in Patients With High-Risk Neuroblastoma and GD2-positive Solid Tumors
Sponsor:
Memorial Sloan Kettering Cancer Center
Organization: